## Core Concept
Hypothyroidism is a condition characterized by the underproduction of thyroid hormones, which play a crucial role in regulating metabolism, heart rate, and cardiac output. Ischemic heart disease (IHD) involves reduced blood flow to the heart due to coronary artery obstruction. Managing hypothyroidism in patients with IHD requires careful consideration to avoid exacerbating cardiac ischemia.

## Why the Correct Answer is Right
The correct approach to treating hypothyroidism in a patient with ischemic heart disease involves cautious replacement of thyroid hormones to avoid increasing myocardial oxygen demand, which could worsen ischemia. The goal is to start with a low dose of thyroid hormone replacement and gradually increase it to avoid over-replacement, which can lead to increased heart rate, contractility, and oxygen demand.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, incorrect statements might suggest aggressive thyroid hormone replacement, ignoring cardiac risks, or using inappropriate medications.
- **Option B:** Similarly, without the content, we assume an incorrect statement might overlook the need for gradual dose titration or fail to consider the patient's cardiac status.
- **Option C:** This option's content is not provided, but an incorrect statement could propose using thyroid hormone analogues or supraphysiological doses without regard for cardiac function.

## Clinical Pearl / High-Yield Fact
A key point to remember is that in patients with hypothyroidism and concomitant ischemic heart disease, **levothyroxine (T4) replacement should be initiated at a low dose (e.g., 25-50 mcg/day)**, and the dose should be titrated upward every 6-8 weeks based on clinical response and laboratory findings, particularly TSH levels. This approach helps minimize the risk of exacerbating cardiac ischemia.

## Correct Answer Line
**Correct Answer: D.**